These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37150296)

  • 1. Epigenetic Modification-Associated Molecular Classification of Gastric Cancer.
    Zeng W; Zhu J; Zeng D; Guo J; Huang G; Zeng Y; Wang L; Bin J; Liao Y; Shi M; Liao W
    Lab Invest; 2023 Sep; 103(9):100170. PubMed ID: 37150296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an RNA modification-related gene predictive model associated with prognosis and immunity in gastric cancer.
    Tuhongjiang A; Wang F; Zhang C; Pang S; Qu Y; Feng B; Amuti G
    BMC Bioinformatics; 2023 Apr; 24(1):147. PubMed ID: 37061682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
    Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.
    Dong B; Wu Y; Zhang J; Gu Y; Xie R; He X; Pang X; Wang X; Cui Y
    Front Immunol; 2023; 14():1162876. PubMed ID: 37215130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.
    Wang G; Yang L; Wang Y; Hu R; Zhang K; Guo T; Chen B; Jiang X; Cui R
    Front Immunol; 2022; 13():939836. PubMed ID: 35898512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
    Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
    J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
    Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
    Du DX; Lian DB; Amin BH; Yan W
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel adenosine signalling-based prognostic signature in gastric cancer and its association with cancer immune features and immunotherapy response.
    Yu Y; Wang Y; Xi D; Wang N; Gao L; Shi Q; Yu R; Li H; Xiang L; Maswikiti EP; Chen H
    Cell Biol Int; 2023 Sep; 47(9):1650-1664. PubMed ID: 37366248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FJX1 overexpression is associated with poor prognosis and promotes gastric cancer proliferation
    Zhang H; Zhang Z; Wang Q; Wang L; Yang Z; Geng Z; Wang Y; Li J; Zuo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):975-984. PubMed ID: 37439170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress in molecular classification of gastric cancer].
    Zhou M; Li G; Zhang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1072-1076. PubMed ID: 27680079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
    Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
    J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.